Radiopharmaceutical production presents specific challenges when it comes to endotoxin testing. Extremely short shelf lives, small batch sizes and strict regulatory requirements leave no margin for error. This webinar will explore how modern bacterial endotoxin testing (BET) solutions can support nuclear pharmacy and radiopharmacy teams in meeting compliance requirements while maintaining speed and operational efficiency.
Why You Should Attend:
- Understand the regulatory landscape: get clarity on regulatory requirements specific to injectable radiopharmaceutical products and how endotoxin limits are calculated and applied in this context.
- Discover fit-for-purpose BET workflows: learn how ready-to-use, pre-filled formats such as bioMérieux's ENDOZYME® II GO STRIPS can dramatically reduce hands-on time and minimize the risk of operator error in time-critical production environments.
- Explore the rFC advantage: understand why recombinant Factor C (rFC) technology offers a robust, animal-component-free alternative to traditional Limulus Amebocyte Lysate (LAL) methods, and how it addresses the interference challenges commonly encountered with radiopharmaceutical matrices.
- Walk away with practical guidance: from method validation to routine quality control release testing, gain actionable insights you can apply directly to your BET workflow.
